Catalyst Wire Dossier Catalyst Wire Dossier

Tapentadol extended-release (Nucynta ER)

Tapentadol · Janssen Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tapentadol extended-release (Nucynta ER), covering 2010-01-13 to 2010-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study for Tapentadol (CG5503) Extended Release for Patients With Painful Diabetic Peripheral Neuropathy [Phase 3]

See pricing